Clinical Trials Browser

Phase 2 × saponin QA-21V1 × Thoracic × Clear all

NCT00004249 2013-06-19

Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial Therapy

Phase 2 Completed

Lung Neoplasms